Ophthalmology, Dental Providers/Dentist, Oral & Maxillofacial Surgery · Novato, CA
NPI
1841301371
Since 2006
Specialty
Ophthalmology, Dental Providers/Dentist, Oral & Maxillofacial Surgery
Code 1223S0112X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1805 Novato Blvd, Suite #1
Novato, CA, 94947
Phone (415) 892-1190
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$16K
1,518 prescriptions
Company payments, 2025
$165
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Mahr F Elder prescribed most often to Medicare patients was Amoxicillin, with 449 prescriptions and refills. In total Mahr F Elder wrote 1,518 Medicare prescriptions that cost $16K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Amoxicillin Generic | 449 | 449 | 379 | $3,454 |
| Chlorhexidine Gluconate Generic | 411 | 413 | 361 | $6,200 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 285 | 285 | 240 | $2,226 |
| Ibuprofen Generic | 99 | 99 | 92 | $568 |
| Azithromycin Generic | 78 | 78 | 63 | $448 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 44 | 44 | 41 | $453 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 40 | 40 | 35 | $389 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 39 | 39 | 31 | $560 |
| Clindamycin Hcl Generic | 27 | 27 | 21 | $261 |
Brand drugs: 0 claims; generic drugs: 1,518 claims; opioid claims: 381.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mahr F Elder $165 ($165 in general payments such as food, travel and fees) from 1 company. The largest payer was Zimvie Inc. with $165.
| Company | Payments | Amount |
|---|---|---|
| Zimvie Inc. ZIMV | 4 | $165 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.